Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Improvement in Prediction of Blood Clots in Cancer Patients

September 9, 2010 By Bio-Medicine.Org

WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ — For cancer
patients, who have an increased risk of developing venous
thromboembolism (VTE) due to a hyperactive blood coagulation
system, there is now an enhanced risk model to predict their chance
of developing blood clots, according to a recent
study
published today in Blood, the journal of the
American Society of Hematology. VTE, the formation of blood clots
in the veins, develops in up to 20 percent of cancer patients and
is one of the leading causes of death among this patient
population. Patients with hematologic malignancies (blood cancers),
particularly those with lymphoma and multiple myeloma, have
relatively high rates of VTE—results from this study found
that 7.2 percent of lymphoma patients and 7.4 percent of the total
study population developed VTE, compared to an estimated general
population incidence rate of .001 percent(1)

“Because the risk of VTE is not equal in all cancer patients and
anticoagulation in cancer patients results in a higher risk of
bleeding complications, categorizing cancer patients according to
their VTE risk is important,” said Ingrid Pabinger, MD, professor
at the Medical University of Vienna and lead author of the study.
Patients with high risk of VTE may benefit from routine
thrombophrophylaxis, preventive treatment for blood clotting, while
low-risk patients tend to have a higher bleeding risk and may not
be the best candidates for routine anticoagulation treatments.

Although there is a current risk prediction model for VTE in
cancer patients, which includes factors such as site of cancer,
body mass index, platelet and leukocyte counts, and hemoglobin
level—all known to increase the risk of cancer-associated
VTE—the new model also incorporates two new biomarkers,
soluble P-selectin (sP-selectin) and D-dimer, to further stratify
patients in

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech